These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 18703936

  • 1. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH, EMBOLDEN II (Trial D1447C00134) Investigators.
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR, BOLDER II Study Group.
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

  • 5. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, BOLDER Study Group.
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [Abstract] [Full Text] [Related]

  • 6. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD, Shen JH, Jindal R, Driver HS, Kennedy SH, Shapiro CM.
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [Abstract] [Full Text] [Related]

  • 7. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.
    Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036
    [Abstract] [Full Text] [Related]

  • 8. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
    J Neurol; 2003 Mar 01; 250(3):347-51. PubMed ID: 12638027
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
    Liebowitz M, Lam RW, Lepola U, Datto C, Sweitzer D, Eriksson H.
    Depress Anxiety; 2010 Oct 01; 27(10):964-76. PubMed ID: 20734365
    [Abstract] [Full Text] [Related]

  • 10. Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
    Vaishnavi S, Alamy S, Zhang W, Connor KM, Davidson JR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1464-9. PubMed ID: 17698275
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
    Weisler RH, Montgomery SA, Earley WR, Szamosi J, Lazarus A.
    Int Clin Psychopharmacol; 2012 Jan 01; 27(1):27-39. PubMed ID: 22027845
    [Abstract] [Full Text] [Related]

  • 12. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U, Onder E.
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec 01; 253(6):307-12. PubMed ID: 14714120
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L, Pitrosky B, Padmanabhan SK, Germain JM, Tourian KA.
    Int Clin Psychopharmacol; 2007 Nov 01; 22(6):338-47. PubMed ID: 17917552
    [Abstract] [Full Text] [Related]

  • 14. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study.
    Cookson J, Keck PE, Ketter TA, Macfadden W.
    Int Clin Psychopharmacol; 2007 Mar 01; 22(2):93-100. PubMed ID: 17293709
    [Abstract] [Full Text] [Related]

  • 15. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M.
    J Affect Disord; 2008 Dec 01; 111(2-3):306-19. PubMed ID: 18774180
    [Abstract] [Full Text] [Related]

  • 16. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    Ketter TA, Jones M, Paulsson B.
    J Affect Disord; 2007 Dec 01; 100 Suppl 1():S45-53. PubMed ID: 17383011
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM, Kluge M, Maras A, Riemann D, Berger M, Kohnen R, Dittmann RW, Gattaz WF.
    Pharmacopsychiatry; 2005 Jan 01; 38(1):13-6. PubMed ID: 15706460
    [Abstract] [Full Text] [Related]

  • 18. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE.
    Bipolar Disord; 2005 Jan 01; 7 Suppl 4():34-40. PubMed ID: 15948765
    [Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
    Katila H, Mezhebovsky I, Mulroy A, Berggren L, Eriksson H, Earley W, Datto C.
    Am J Geriatr Psychiatry; 2013 Aug 01; 21(8):769-84. PubMed ID: 23567397
    [Abstract] [Full Text] [Related]

  • 20. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF, Sayler ME, Koke SC, Pearson DK, Tollefson GD.
    Depress Anxiety; 1997 Aug 01; 6(1):31-9. PubMed ID: 9394873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.